AeviceMD Wearable Stethoscope Monitoring System

Aevice Health Pte Ltd is a Singapore medical device company founded by CEO Adrian Ang, who grew up with asthma, together with co-founders including CTO Rex Tan. It aims to give clinicians continuous visibility of chronic respiratory diseases such as asthma between clinic visits, especially at night when symptoms are often missed.

AeviceMD is a reusable, rechargeable wearable stethoscope the size of a bottle cap, weighing 9 g, worn on the chest during sleep. It continuously records lung sounds and computes wheeze detection, respiratory rate and heart rate, alongside medication tracking, and sends the data to a clinician platform for later playback, review and analysis. It is sold to hospitals, clinics and remote monitoring programmes, and is cleared for patients aged three and above.

• Wearable stethoscope: 9 g, bottle-cap-sized sensor that records lung sounds continuously during sleep.
• Wheeze detection: identifies sounds suggestive of wheeze for clinician review.
• Vital signs: tracks respiratory rate and heart rate alongside lung sounds.
• Medication tracking: links symptom data with treatment use.
• Clinician platform: stores recordings for playback, review and analysis by care teams.
• Reusable design: rechargeable, non-invasive device suitable for children aged three and above.

Private hospitals and paediatric clinics in Vietnam can run home asthma monitoring programmes for children during pollution seasons. Respiratory departments can follow up patients after discharge to catch deterioration early. Clinical research organisations can use continuous lung sound recordings as objective endpoints in respiratory drug studies.

Clinicians get objective night-time lung sound data instead of relying on recall from parents or patients. Continuous wheeze detection supports earlier intervention, which the company links to fewer readmissions and emergency visits. The 9 g, bottle-cap-sized sensor is comfortable enough for young children to wear during sleep. Regulatory clearances in the US, Singapore and Australia simplify adoption by hospital groups.

Chronic respiratory diseases are a large burden across Asia, and air pollution and seasonal haze make symptoms harder to control. Health systems are shifting care from hospitals to homes through remote patient monitoring to reduce costly admissions. Private hospital groups in Southeast Asia, including in Vietnam, are building paediatric and chronic care programmes that can use connected medical sensors.

Registered as Aevice Health Pte Ltd in Singapore; CEO and founder Adrian Ang, CTO Rex Tan; board includes Willson Cuaca of East Ventures and Nirdesh Gupta of Coronet Ventures. Holds US FDA 510(k) clearances K223382, K243603 and K260140, Singapore HSA approval and Australian TGA listing (ARTG 521434). Won a CES Innovation Awards 2023 Best of Innovation in Digital Health.